HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY
Clinical trials for HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection shows promise for long-term prevention of rare swelling disorder
Disease control CompletedThis study tested the long-term safety and effectiveness of garadacimab, a monthly injection, for preventing attacks of hereditary angioedema (HAE) — a rare condition causing severe swelling. 171 people aged 12 and older who had frequent HAE attacks took part. The goal was to see…
Matched conditions: HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
HAE patients and caregivers speak out: the hidden costs of On-Demand treatment
Knowledge-focused CompletedThis completed French survey of 300 hereditary angioedema (HAE) patients and their caregivers aimed to understand the challenges of using on-demand treatments for HAE attacks. Researchers collected data on attack frequency, severity, treatment delays, hospitalizations, and the fi…
Matched conditions: HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC